Trials / Recruiting
RecruitingNCT06725940
GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer
Clinical Study on the Evaluation of Neoadjuvant Therapy Efficacy in Breast Cancer Using PET/CT With Granzyme B Imaging Probe
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To explore the efficacy of 68Ga-GZMB PET/CT in assessing the response to neoadjuvant therapy for breast cancer, and to investigate the optimal SUVmax threshold of 68Ga-GZMB PET/CT for predicting pathological complete response (pCR), aiming to provide a new and effective means for accurately and non-invasively evaluating the efficacy of neoadjuvant therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 68Ga-GZMB PET/CT | 68Ga-GZMB PET/CT |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-11-01
- Completion
- 2025-11-01
- First posted
- 2024-12-10
- Last updated
- 2024-12-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06725940. Inclusion in this directory is not an endorsement.